How should healthcare organisations secure AI and LLM systems that process sensitive patient data?

How healthcare organisations should frame AI and LLM security

For healthcare, AI and LLM security is primarily a data governance and access control problem. The main question is not whether the model is “smart enough,” but whether the system can safely handle protected health information, limit who can reach it, and prevent sensitive data from leaking through prompts, logs, connectors, or downstream integrations.

That means the security boundary has to include the application, the model interface, the retrieval layer, and any external tools or plugins. Permission-aware retrieval matters because an LLM will faithfully surface whatever the surrounding system exposes to it, including data a user should not see.

Healthcare teams should also treat model inputs and outputs as part of the data lifecycle. If prompts, embeddings, transcripts, or evaluation traces contain patient information, those artefacts need the same retention, access, and masking discipline applied to other clinical systems. That is especially important when vendors host the model or when internal teams use shared AI services across departments.

Why the surrounding platform is usually the weak point

Most healthcare AI failures do not come from the model in isolation. They come from weak identity and trust boundaries around the model, such as over-permissive service accounts, exposed API keys, unrestricted connectors, insecure RAG pipelines, or logging that captures patient text in clear form. In practice, the LLM often becomes the place where existing security gaps are amplified.

AI infrastructure workload identity becomes critical when notebooks, inference services, data stores, and orchestration jobs all need distinct, limited access. If those components share credentials or reuse broad tokens, an incident in one layer can quickly expose clinical data in another.

Third-party integrations are another common pressure point. Healthcare organisations frequently connect AI systems to records platforms, knowledge bases, ticketing systems, or summarisation tools, and each connector creates a new path for accidental disclosure or abuse. AI supply chain control helps teams track which models, packages, tools, and hosted components are actually in use, so security review is based on the real dependency set rather than assumptions.

When staff use AI to draft clinical notes, summarise correspondence, or search internal records, the risk is not just leakage but over-trust. Outputs may be fluent, incomplete, or subtly wrong, so the surrounding workflow needs human validation before anything affects patient care, coding, or operational decisions.

Controls healthcare teams should prioritise before wider deployment

Start with access minimisation, encryption, and strict separation between production patient data and non-production AI environments. Use data minimisation for prompts and retrieval, redact where possible, and ensure that training or fine-tuning data is approved, provenance-checked, and excluded from unnecessary reuse. If the AI system cannot operate without broad access to live records, the design should be reconsidered.

Testing should cover prompt injection, data extraction, connector abuse, and insecure output handling, not just conventional web flaws. OWASP Agentic AI Top 10 is useful here because it highlights identity and privilege abuse, tool misuse, and supply chain failure modes that matter when AI systems can take action, call tools, or move data between systems.

Healthcare organisations should also define who can approve use cases, who owns the data flow, and who is allowed to connect a model to clinical or operational systems. That governance layer is what prevents “shadow AI” from becoming an unsupervised route into regulated data. NIST AI Risk Management Framework is a useful organising reference for that governance, especially where accountability, monitoring, and validation have to be documented across the AI lifecycle.

For organisations handling patient information at scale, the right control set also needs to reflect regulatory obligations, especially around special category data, security of processing, and privacy by design. GDPR is relevant wherever EU personal data is involved, and it reinforces the need to justify collection, limit processing, and prove that safeguards were designed into the system rather than added later.

Risk and Threat Considerations

Healthcare AI systems create a concentrated exposure point because one interface can touch many records, many users, and many downstream tools. If the model or its retrieval layer is over-permissioned, a single compromised account, poisoned prompt, or exposed connector can reveal patient data well beyond the original query scope.

Failure mechanism: Weak trust boundaries around prompts, retrieval, logging, or connectors let an attacker or careless user move sensitive data through the AI stack, exfiltrate it in responses, or reuse it through linked services.

Impact: The result can include disclosure of protected health information, regulatory breach, unsafe clinical decision support, and loss of confidence in the AI system, even when the underlying model itself was not compromised.

Practitioner Guidance

What to prioritise: Treat the first security review as a data-flow and permission exercise, not a model-quality exercise. Map where patient data enters, where it is stored, which identities can query it, and which tools the AI can call on behalf of users.

What to verify: Confirm that prompts, logs, embeddings, cached outputs, and evaluation artefacts are classified, retained, and accessed according to the sensitivity of the underlying patient data. If any of those stores are broadly readable, the AI deployment is not ready for production.

Decision rule: If an AI feature can reach live patient data or take an operational action, require stronger approval, tighter scoping, and explicit ownership before rollout. If it is only a drafting aid on de-identified text, the control burden is lower, but output review is still necessary.

Practitioner takeaway: The safest healthcare AI deployments are the ones where data exposure is limited by design, not by hope, and where every privileged path into patient data is intentional, monitored, and easy to revoke.

Related resources from NHI Mgmt Group

• Secure AI
• How should healthcare organisations secure sensitive clinical files and credentials when data sharing spans multiple teams and systems?
• How should enterprises secure AI systems that access sensitive data at runtime?
• What should healthcare data handlers do first when API-based fulfillment systems expose sensitive patient information?